{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:58:55Z","timestamp":1790233135008,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Community's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"European Community's Seventh Framework Programme","award":["226556"],"award-info":[{"award-number":["226556"]}]},{"DOI":"10.13039\/501100011091","name":"Belgian Federal Public Service for Health, Food Chain Safety and Environment","doi-asserted-by":"crossref","award":["RI14\/2-26"],"award-info":[{"award-number":["RI14\/2-26"]}],"id":[{"id":"10.13039\/501100011091","id-type":"DOI","asserted-by":"crossref"}]},{"name":"French Agence Nationale de la Recherche","award":["ANR-14-ANWA-0007-01"],"award-info":[{"award-number":["ANR-14-ANWA-0007-01"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.074","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:26:05Z","timestamp":1521386765000},"page":"2193-2198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs"],"prefix":"10.1016","volume":"36","author":[{"given":"Annebel R.","family":"De Vleeschauwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Watier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine A.","family":"Lacour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zientara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labib","family":"Bakkali-Kassimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klonjkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.074_b0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0079-6107(93)90016-D","article-title":"Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure","volume":"60","author":"Belsham","year":"1993","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.20506\/rst.26.1.1724","article-title":"A brief history of vaccines and vaccination","volume":"26","author":"Lombard","year":"2007","journal-title":"Rev Sci Tech Int Off Epizoot"},{"key":"10.1016\/j.vaccine.2018.02.074_b0015","doi-asserted-by":"crossref","first-page":"20120381","DOI":"10.1098\/rstb.2012.0381","article-title":"Elimination of foot-and-mouth disease in South America: lessons and challenges","volume":"368","author":"Naranjo","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2018.02.074_b0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetmic.2016.12.018","article-title":"Foot-and-mouth disease vaccines","volume":"206","author":"Diaz-San Segundo","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2005.04.014","article-title":"Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine","volume":"337","author":"Pacheco","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.074_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virol.2016.12.021","article-title":"Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine","volume":"502","author":"Fernandez-Sainz","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.074_b0035","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1016\/j.vaccine.2008.09.044","article-title":"Antigen delivery systems for veterinary vaccine development","volume":"26","author":"Brun","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2010.11.068","article-title":"Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep","volume":"29","author":"Bouet-Cararo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0045","doi-asserted-by":"crossref","unstructured":"Szelechowski M, Bergeron C, Gonzalez-Dunia D, Klonjkowski B. Production and purification of non replicative canine adenovirus type 2 derived vectors. J Vis Exp JoVE 2013:50833. http:\/\/doi.org\/10.3791\/50833.","DOI":"10.3791\/50833"},{"key":"10.1016\/j.vaccine.2018.02.074_b0050","first-page":"467","article-title":"Canine adenovirus based rabies vaccines","volume":"131","author":"Tordo","year":"2008","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0055","doi-asserted-by":"crossref","first-page":"e52513","DOI":"10.1371\/journal.pone.0052513","article-title":"Canine recombinant adenovirus vector induces an immunogenicity-related gene expression profile in skin-migrated CD11b+ -Type DCs","volume":"7","author":"Contreras","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.02.074_b0060","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1089\/hum.1997.8.17-2103","article-title":"A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo","volume":"8","author":"Klonjkowski","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2018.02.074_b0065","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1111\/tbed.12255","article-title":"A refined guinea pig model of foot-and-mouth disease virus infection for assessing the efficacy of antiviral compounds","volume":"63","author":"De Vleeschauwer","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.02.074_b0070","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2018.02.074_b0075","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.rvsc.2013.07.007","article-title":"Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge","volume":"95","author":"Bhat","year":"2013","journal-title":"Res Vet Sci"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2018.02.074_b0080","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1099\/0022-1317-76-12-3089","article-title":"Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system","volume":"76","author":"Abrams","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2007.06.029","article-title":"Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18","volume":"121","author":"Ma","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/viro.1999.9717","article-title":"Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs","volume":"259","author":"Sanz-Parra","year":"1999","journal-title":"Virology"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2018.02.074_b0095","doi-asserted-by":"crossref","first-page":"G48","DOI":"10.1016\/j.vaccine.2008.09.066","article-title":"Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease","volume":"26","author":"Lu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0100","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0264-410X(00)00384-4","article-title":"Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs","volume":"19","author":"Mayr","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0105","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2016.06.008","article-title":"Application of mouse model for effective evaluation of foot-and-mouth disease vaccine","volume":"34","author":"Lee","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vetmic.2013.04.017","article-title":"Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus","volume":"165","author":"Romanutti","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.rvsc.2012.12.004","article-title":"Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice","volume":"94","author":"Zhou","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2018.02.074_b0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2004.11.005","article-title":"Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice","volume":"332","author":"Salguero","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.074_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jviromet.2007.08.027","article-title":"Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs","volume":"147","author":"Yao","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.02.074_b0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-1702(02)00357-X","article-title":"Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type \u201cO\u201d produced in Pichia pastoris","volume":"92","author":"Balamurugan","year":"2003","journal-title":"Virus Res"},{"issue":"146","key":"10.1016\/j.vaccine.2018.02.074_b0135","first-page":"749","article-title":"A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle","volume":"1991","author":"Collen","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.vaccine.2018.02.074_b0140","first-page":"406","article-title":"Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle","volume":"75","author":"van Lierop","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2018.02.074_b0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0264-410X(92)90504-D","article-title":"Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain","volume":"10","author":"Gonz\u00e1lez","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4149\/av_2012_02_91","article-title":"Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs","volume":"56","author":"Rao","year":"2012","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jgm.723","article-title":"Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus","volume":"7","author":"Yang","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2018.02.074_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2016.04.008","article-title":"Immunoprotective mechanisms in swine within the \u201cgrey zone\u201d in antibody response after immunization with foot-and-mouth disease vaccine","volume":"220","author":"Zhang","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.02.074_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5501\/wjv.v4.i3.295","article-title":"Diagnostic assays developed for the control of foot-and-mouth disease in India","volume":"4","author":"Sharma","year":"2015","journal-title":"World J Virol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0264-410X(97)00227-2","article-title":"Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA","volume":"16","author":"Mackay","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0175","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.vaccine.2005.09.057","article-title":"Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle","volume":"24","author":"Clavijo","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biologicals.2016.02.004","article-title":"Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection","volume":"44","author":"Biswal","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.02.074_b0185","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1016\/j.vaccine.2006.04.050","article-title":"Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus","volume":"24","author":"Brocchi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.074_b0190","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s007050050390","article-title":"Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus","volume":"143","author":"S\u00f8rensen","year":"1998","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jviromet.2011.09.011","article-title":"Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus","volume":"178","author":"Jaworski","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.02.074_b0200","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1128\/JVI.05127-11","article-title":"Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo","volume":"85","author":"Cubillos-Zapata","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.074_b0205","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2016.09.027","article-title":"Combination of Adt-O1Manisa and Ad5-boIFN\u03bb3 induces early protective immunity against foot-and-mouth disease in cattle","volume":"499","author":"Diaz-San Segundo","year":"2016","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:56Z","timestamp":1759400756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18302615"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}